321 related articles for article (PubMed ID: 28108861)
1. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
2. In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
De Meulenaere V; Descamps B; De Wever O; Vanhove C; Deblaere K
PLoS One; 2020; 15(12):e0243156. PubMed ID: 33264355
[TBL] [Abstract][Full Text] [Related]
3. Liposomal Irinotecan Achieves Significant Survival and Tumor Burden Control in a Triple Negative Breast Cancer Model of Spontaneous Metastasis.
Bernards N; Ventura M; Fricke IB; Hendriks BS; Fitzgerald J; Lee H; Zheng J
Mol Pharm; 2018 Sep; 15(9):4132-4138. PubMed ID: 30059232
[TBL] [Abstract][Full Text] [Related]
4. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
Wan X; Zheng X; Pang X; Pang Z; Zhao J; Zhang Z; Jiang T; Xu W; Zhang Q; Jiang X
Oncotarget; 2016 Jun; 7(23):34038-51. PubMed ID: 27086917
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles target early-stage breast cancer metastasis in vivo.
Goldman E; Zinger A; da Silva D; Yaari Z; Kajal A; Vardi-Oknin D; Goldfeder M; Schroeder JE; Shainsky-Roitman J; Hershkovitz D; Schroeder A
Nanotechnology; 2017 Oct; 28(43):43LT01. PubMed ID: 28872058
[TBL] [Abstract][Full Text] [Related]
8. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY
Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614
[TBL] [Abstract][Full Text] [Related]
9. Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.
Zarghami N; Murrell DH; Jensen MD; Dick FA; Chambers AF; Foster PJ; Wong E
Radiat Oncol; 2018 Jun; 13(1):104. PubMed ID: 29859114
[TBL] [Abstract][Full Text] [Related]
10. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
[TBL] [Abstract][Full Text] [Related]
11. Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
Arroyo-Crespo JJ; Armiñán A; Charbonnier D; Deladriere C; Palomino-Schätzlein M; Lamas-Domingo R; Forteza J; Pineda-Lucena A; Vicent MJ
Int J Cancer; 2019 Oct; 145(8):2267-2281. PubMed ID: 30860605
[TBL] [Abstract][Full Text] [Related]
12. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
13. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
[TBL] [Abstract][Full Text] [Related]
14. MRI reveals increased tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer.
Mustafi D; Fernandez S; Markiewicz E; Fan X; Zamora M; Mueller J; Brady MJ; Conzen SD; Karczmar GS
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28661075
[TBL] [Abstract][Full Text] [Related]
15. RSK1 promotes murine breast cancer growth and metastasis.
Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 as a novel therapeutic target for triple negative breast cancer.
Castro NP; Fedorova-Abrams ND; Merchant AS; Rangel MC; Nagaoka T; Karasawa H; Klauzinska M; Hewitt SM; Biswas K; Sharan SK; Salomon DS
Oncotarget; 2015 May; 6(14):11910-29. PubMed ID: 26059540
[TBL] [Abstract][Full Text] [Related]
17. αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
Malin D; Strekalova E; Petrovic V; Deal AM; Al Ahmad A; Adamo B; Miller CR; Ugolkov A; Livasy C; Fritchie K; Hamilton E; Blackwell K; Geradts J; Ewend M; Carey L; Shusta EV; Anders CK; Cryns VL
Clin Cancer Res; 2014 Jan; 20(1):56-67. PubMed ID: 24132917
[TBL] [Abstract][Full Text] [Related]
18. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
[TBL] [Abstract][Full Text] [Related]
19. Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis.
Kim SH; Redvers RP; Chi LH; Ling X; Lucke AJ; Reid RC; Fairlie DP; Martin ACBM; Anderson RL; Denoyer D; Pouliot N
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29784888
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.
Avraham HK; Jiang S; Fu Y; Nakshatri H; Ovadia H; Avraham S
J Pathol; 2014 Feb; 232(3):369-81. PubMed ID: 24421076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
